CIAM
JANX icon

Caitong International Asset Management’s Janux Therapeutics JANX Stock Holding History

Caitong International Asset Management’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.31K Buy
+85
New +$1.23K ﹤0.01% 1481
2026
Q1 		– Sell
-3,713
Closed -$51.2K – 2825
2025
Q4 		$51.2K Buy
+3,713
New +$87.3K 0.01% 692
2025
Q2 		– Sell
-312
Closed -$8.42K – 2232
2025
Q1 		$8.42K Sell
312
-1,079
-78% -$40.7K 0.01% 896
2024
Q4 		$74.5K Buy
+1,391
New +$73.6K 0.07% 320

Other funds holding JANX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NNPTE
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne Warszawa, Poland $1.83B AUM 331.52% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
WG
Winton Group London, United Kingdom $3.09B AUM 40.4% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Caitong International Asset Management's JANX Position: Q2 2026 in Review

Caitong International Asset Management opened a new position in Janux Therapeutics (JANX) in Q2 2026: 85 shares worth $1.31K. The stake represents ﹤0.01% of the portfolio and ranks #1481 among its holdings. This is a return to the name: Caitong International Asset Management previously reported a position in JANX as recently as Q4 2025.

Caitong International Asset Management first reported a position in JANX in Q4 2024 and has held it in 4 quarters since. The position peaked at $74.5K in Q4 2024. 61 funds tracked by Wall St. Rank hold JANX as of Q2 2026.

  • Caitong International Asset Management held 85 shares of Janux Therapeutics worth $1.31K as of Q2 2026.
  • Janux Therapeutics was a new Caitong International Asset Management position in Q2 2026.
  • Janux Therapeutics made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #1481 holding.
  • Caitong International Asset Management first reported a position in Janux Therapeutics in Q4 2024 and has held it in 4 quarters since.
  • Caitong International Asset Management's Janux Therapeutics position peaked at $74.5K in Q4 2024.
  • 61 funds tracked by Wall St. Rank held Janux Therapeutics as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.